Lauren P. McLaughlin

408 total citations
47 papers, 284 citations indexed

About

Lauren P. McLaughlin is a scholar working on Oncology, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Lauren P. McLaughlin has authored 47 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Economics and Econometrics and 6 papers in Epidemiology. Recurrent topics in Lauren P. McLaughlin's work include Law, Economics, and Judicial Systems (7 papers), Cytomegalovirus and herpesvirus research (6 papers) and CAR-T cell therapy research (5 papers). Lauren P. McLaughlin is often cited by papers focused on Law, Economics, and Judicial Systems (7 papers), Cytomegalovirus and herpesvirus research (6 papers) and CAR-T cell therapy research (5 papers). Lauren P. McLaughlin collaborates with scholars based in United States, Canada and Israel. Lauren P. McLaughlin's co-authors include Catherine M. Bollard, Michael D. Keller, Stephen Gottschalk, Cliona M. Rooney, Birte Wistinghausen, Patrick J. Hanley, Carolina Colli Cruz, Brian Petersen, Jeff Dunn and Robert P. Dellavalle and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Lauren P. McLaughlin

38 papers receiving 277 citations

Peers

Countries citing papers authored by Lauren P. McLaughlin

Since Specialization

Citations

This map shows the geographic impact of Lauren P. McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren P. McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren P. McLaughlin more than expected).

Fields of papers citing papers by Lauren P. McLaughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren P. McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren P. McLaughlin. The network helps show where Lauren P. McLaughlin may publish in the future.

Co-authorship network of co-authors of Lauren P. McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren P. McLaughlin. A scholar is included among the top collaborators of Lauren P. McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren P. McLaughlin. Lauren P. McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 1/2 study to investigate the safety and efficacy of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced solid tumors. 2024 ·Journal of Clinical Oncology ·Adam J. Schoenfeld, Allison Betof Warner, Jason Chesney, Sajeve Thomas, Omid Hamid, Gino K. In, Alexander N. Shoushtari, (unknown), Parameswaran Hari, Giridharan Ramsingh, (unknown), Prakash Prabhakar, Lauren P. McLaughlin, Kai He	4
2	The Challenges of Proving a Labor Inefficiency Claim 2023 ·Civil engineering ·(unknown), Lauren P. McLaughlin	1
3	How should multiple myeloma research change in a patient-oriented world? Findings and lessons from the pan-Canadian myeloma priority setting partnership 2023 ·Research Involvement and Engagement ·Sarah Bridges, (unknown), Lauren P. McLaughlin, (unknown), (unknown), Donna Reece, Kevin Song, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tony Reiman	1
4	New Zealand falcons (Falco novaeseelandiae) hunting petrels at night and underground during the day 2022 ·Notornis ·Colin M. Miskelly, Lauren P. McLaughlin, (unknown)	0
5	Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique Study 2021 ·MDM Policy & Practice ·Brett Hauber, (unknown), Mo Zhou, Shomesh E. Chaudhuri, Heather L. Benz, (unknown), (unknown), Anindita Saha, Martin Ho, Stephanie Christopher, (unknown), Mary C. Sheehan, (unknown), Lauren P. McLaughlin, Katrina Gwinn, Andrew W. Lo, Murray Sheldon	18
6	Foundations for a Patient-Reported Natural History of Parkinson Disease: Cross sectional Analysis of the MJFF Fox Insight (FI) Platform (P2.056) 2018 ·Neurology ·(unknown), Andrew Nguyen, Lauren P. McLaughlin, (unknown), Catherine Kopil, Emily Flagg, (unknown), Ira Shoulson	1
7	Adoptive T Cell Therapy for Epstein–Barr Virus Complications in Patients With Primary Immunodeficiency Disorders 2018 ·Frontiers in Immunology ·Lauren P. McLaughlin, Catherine M. Bollard, Michael D. Keller	21
8	Engineering Inspector Unable To Fend Off Negligence Claims 2018 ·Civil engineering ·(unknown), Lauren P. McLaughlin	1
9	EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation 2018 ·Blood ·Lauren P. McLaughlin, Rayne H. Rouce, Stephen Gottschalk, Vicky Torrano, George Carrum, Meng‐Fen Wu, Fahmida Hoq, Bambi Grilley, (unknown), Patrick J. Hanley, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Catherine M. Bollard	56
10	Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency Disorders 2017 ·Current Allergy and Asthma Reports ·Lauren P. McLaughlin, Catherine M. Bollard, Michael D. Keller	7
11	Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s Disease 2016 ·Journal of Parkinson s Disease ·Lauren E. Heusinkveld, Mallory L. Hacker, Maxim Turchan, (unknown), (unknown), William Fisher, Lauren P. McLaughlin, (unknown), David Charles	11
12	Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes 2016 ·Cytotherapy ·Lauren P. McLaughlin, Haili Lang, Elizabeth D. Williams, (unknown), Allison B. Powell, Carolina Colli Cruz, Anamaris M. Colberg‐Poley, Cecilia Barese, Patrick J. Hanley, Catherine M. Bollard, Michael D. Keller	27
13	Management of post-transplant lymphoproliferative disorders 2016 ·Current Opinion in Pediatrics ·(unknown), Lauren P. McLaughlin, Birte Wistinghausen	22
14	EBV-Directed T Cell Therapeutics for EBV-Associated Lymphomas 2016 ·Methods in molecular biology ·Lauren P. McLaughlin, Stephen Gottschalk, Cliona M. Rooney, Catherine M. Bollard	16
15	Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advances 2015 ·Therapeutic Advances in Hematology ·Lauren P. McLaughlin, Carolina Colli Cruz, Catherine M. Bollard	10
16	Topical Antimicrobial Treatment of Acne Vulgaris 2012 ·American Journal of Clinical Dermatology ·(unknown), Jeff Dunn, (unknown), Brian Petersen, Lauren P. McLaughlin, (unknown), (unknown), Robert P. Dellavalle	36
17	Introduction: US Dermatologic Health Care Needs Assessment 2011 ·Dermatologic Clinics ·(unknown), Lauren P. McLaughlin, (unknown), Robert P. Dellavalle	2
18	Specially Drafted Terms Prevail over Those Preprinted 2007 ·Civil engineering ·(unknown), Lauren P. McLaughlin	1
19	Enforcing Liquidated Damages: How Much is Too Much? 2004 ·Civil engineering ·(unknown), Lauren P. McLaughlin	2
20	Prophylactic oophorectomy in Ontario 2001 ·Familial Cancer ·L. Elit, Barry P. Rosen, Vivek Goel, Lauren P. McLaughlin, (unknown), J. Shime, Steven A. Narod	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact